An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given conditional approval to enter human trials, according to Taiwan's Food and Drug Administration (FDA) on Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
NSB major general impeached for indecent assault
11/21/2024 06:19 PM - Society
Education ministry-funded youth overseas program to start in 2025
11/21/2024 06:08 PM - Politics
Labor minister offers resignation over bullying suicide case
11/21/2024 05:59 PM - Business
NDC chief upbeat about Taiwan's economy
11/21/2024 05:30 PM - Business
Half of Taiwan's companies to offer raises in 2025: Survey
11/21/2024 04:56 PM